Nimotuzumab in combination with intensity modulated radiotherapy improve survival in locally advanced head and neck squamous cell carcinoma (LA-HNSCC): A multicenter-based real-world study
机构:[1]Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China[2]Sichuan Cancer hospital institute, Chengdu, China四川省肿瘤医院[3]Department of Oral and Maxillofacial Head & Neck Oncology, Shanghai Ninth People’s Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China[4]PLA General Hospital, Beijing, China[5]Sun Yat-Sen University Cancer Center, Guangzhou, China[6]Beijing Cancer Hospital, Beijing, China[7]Tianjin Medical University Cancer Institute & Hospital, Tianjin, China[8]Fujian Cancer Hospital, Beijing, China[9]Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China[10]Cancer Hospital/Institute, Chengdu, Sichuan, China[11]Department of Oral and Maxillofacial Head & Neck Oncology, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai, China[12]Chinese PLA General Hospital, Beijing, China[13]Tianjin Cancer Hospital, Tianjin, China[14]Fujian Cancer Hospital, Fujian, China[15]National Cancer Center, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China[16]Sichuan Cancer Hospital and Research Institute, Chengdu, China四川省肿瘤医院[17]Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China[18]Biotech Pharmaceutical Ltd., Corp, Beijing, China
第一作者机构:[1]Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
推荐引用方式(GB/T 7714):
Junlin Yi,jin yi Lang,Chenping Zhang,et al.Nimotuzumab in combination with intensity modulated radiotherapy improve survival in locally advanced head and neck squamous cell carcinoma (LA-HNSCC): A multicenter-based real-world study[J].JOURNAL OF CLINICAL ONCOLOGY.2023,41(16_SUPPL):E18006-E18006.doi:10.1200/JCO.2023.41.16_suppl.e18006.
APA:
Junlin Yi,jin yi Lang,Chenping Zhang,Xin-Xin Zhang,Shao-xiong Wu...&Xianhong Bai.(2023).Nimotuzumab in combination with intensity modulated radiotherapy improve survival in locally advanced head and neck squamous cell carcinoma (LA-HNSCC): A multicenter-based real-world study.JOURNAL OF CLINICAL ONCOLOGY,41,(16_SUPPL)
MLA:
Junlin Yi,et al."Nimotuzumab in combination with intensity modulated radiotherapy improve survival in locally advanced head and neck squamous cell carcinoma (LA-HNSCC): A multicenter-based real-world study".JOURNAL OF CLINICAL ONCOLOGY 41..16_SUPPL(2023):E18006-E18006